Zioptan Eyedrops Approved for Glaucoma, Ocular Hypertension

Merck’s Zioptan drops (tafluprost ophthalmic solution) has been approved by the U.S. Food and Drug Administration to lower pressure within the eye among people with high blood pressure of the eye (ocular hypertension) or open-angle glaucoma, the most common form of the disease.
Source

Leave a Comment